Pneumococcal Vaccine Industry Research Report 2024

Pneumococcal Vaccine Industry Research Report 2024


Summary
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

According to APO Research, the global Pneumococcal Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.

The report will help the Pneumococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
PfizerGSKMSDSanofipasteurCDIBPPneumococcal Vaccine segment by Type
PPSV 23PCV 7/13PCV 10Pneumococcal Vaccine segment by End Use
rChildAdultPneumococcal Vaccine Segment by Region
North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaChina TaiwanIndonesiaThailandMalaysiaLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaUAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pneumococcal Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pneumococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by End Use
r, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pneumococcal Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Pneumococcal Vaccine Sales (2019-2030)
2.2.3 Global Pneumococcal Vaccine Market Average Price (2019-2030)
2.3 Pneumococcal Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 PPSV 23
2.3.3 PCV 7/13
2.3.4 PCV 10
2.4 Pneumococcal Vaccine by End User
2.4.1 Market Value Comparison by End User (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Child
2.4.3 Adult
3 Market Competitive Landscape by Manufacturers
3.1 Global Pneumococcal Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Pneumococcal Vaccine Sales (K Doses) of Manufacturers (2019-2024)
3.3 Global Pneumococcal Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Pneumococcal Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Pneumococcal Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pneumococcal Vaccine, Product Type & Application
3.8 Global Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
3.9 Global Pneumococcal Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Pfizer
4.1.1 Pfizer Company Information
4.1.2 Pfizer Business Overview
4.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
4.1.5 Pfizer Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Pneumococcal Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 MSD
4.3.1 MSD Company Information
4.3.2 MSD Business Overview
4.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 MSD Pneumococcal Vaccine Product Portfolio
4.3.5 MSD Recent Developments
4.4 Sanofipasteur
4.4.1 Sanofipasteur Company Information
4.4.2 Sanofipasteur Business Overview
4.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
4.4.5 Sanofipasteur Recent Developments
4.5 CDIBP
4.5.1 CDIBP Company Information
4.5.2 CDIBP Business Overview
4.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
4.5.5 CDIBP Recent Developments
5 Global Pneumococcal Vaccine Market Scenario by Region
5.1 Global Pneumococcal Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pneumococcal Vaccine Sales by Region: 2019-2030
5.2.1 Global Pneumococcal Vaccine Sales by Region: 2019-2024
5.2.2 Global Pneumococcal Vaccine Sales by Region: 2025-2030
5.3 Global Pneumococcal Vaccine Revenue by Region: 2019-2030
5.3.1 Global Pneumococcal Vaccine Revenue by Region: 2019-2024
5.3.2 Global Pneumococcal Vaccine Revenue by Region: 2025-2030
5.4 North America Pneumococcal Vaccine Market Facts & Figures by Country
5.4.1 North America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Pneumococcal Vaccine Sales by Country (2019-2030)
5.4.3 North America Pneumococcal Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Pneumococcal Vaccine Market Facts & Figures by Country
5.5.1 Europe Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Pneumococcal Vaccine Sales by Country (2019-2030)
5.5.3 Europe Pneumococcal Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Pneumococcal Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pneumococcal Vaccine Market Facts & Figures by Country
5.7.1 Latin America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Pneumococcal Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Pneumococcal Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Pneumococcal Vaccine Sales by Type (2019-2030)
6.1.1 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (K Doses)
6.1.2 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030)
6.2.1 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Pneumococcal Vaccine Price by Type (2019-2030)
7 Segment by End User
7.1 Global Pneumococcal Vaccine Sales by End User (2019-2030)
7.1.1 Global Pneumococcal Vaccine Sales by End User (2019-2030) & (K Doses)
7.1.2 Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
7.2 Global Pneumococcal Vaccine Revenue by End User (2019-2030)
7.2.1 Global Pneumococcal Vaccine Sales by End User (2019-2030) & (US$ Million)
7.2.2 Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
7.3 Global Pneumococcal Vaccine Price by End User (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Pneumococcal Vaccine Value Chain Analysis
8.1.1 Pneumococcal Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pneumococcal Vaccine Production Mode & Process
8.2 Pneumococcal Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pneumococcal Vaccine Distributors
8.2.3 Pneumococcal Vaccine Customers
9 Global Pneumococcal Vaccine Analyzing Market Dynamics
9.1 Pneumococcal Vaccine Industry Trends
9.2 Pneumococcal Vaccine Industry Drivers
9.3 Pneumococcal Vaccine Industry Opportunities and Challenges
9.4 Pneumococcal Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings